The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015. DOI: 10.4244/EIJY15M11_07

1. Hartcentrum Hasselt, Hasselt, Belgium; 2. Erasmus MC, Rotterdam, The Netherlands; 3. Bern University Hospital, Bern, Switzerland; 4. Université Paris Diderot-Sorbonne Paris Cité, DHU-FIRE, AH-HP and INSERM U-1148, Paris, France; 5. Imperial College Lon

Aims: The GLOBAL LEADERS trial is a superiority study in patients undergoing percutaneous coronary intervention, with a uniform use of Biolimus A9-eluting stents (BES) and bivalirudin. GL

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry